SCHEMBL8295392

SCHEMBL8295392

O=C(N[C@H]1CCCCC/C=C\[C@@H]2C[C@H]2NC(=O)[C@@H]2C[C@@H](OC(=O)N3CCc4ccccc4C3)CN2C1=O)OCCF

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ ADRB3 P13945 1/20 0.31
▸ ADRA2B P18089 1/20 0.31
▸ ADRA2C P18825 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ MOGAT2 Q3SYC2 1/20 0.31
▸ KEAP1 Q14145 1/20 0.31
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ FAP Q12884 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8294160 0.89 DRD2 (0.35) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL13896394 0.88 POLB (0.40) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL8278885 0.87 ADRB3 (0.33) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL3968060 0.86 ADRB3 (0.44) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL3968058 0.86 ADRB3 (0.44) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL3968065 0.86 ADRB3 (0.44) ALDH1A1MAPTTDP1POLBADRB3
SCHEMBL8278219 0.84 POLB (0.33) ALDH1A1MAPTTDP1POLBLMNA
SCHEMBL8278256 0.83 REN (0.33) ADRB3ADRA2BADRA2C
SCHEMBL13886148 0.83 REN (0.33) ADRB3ADRA2BADRA2C
SCHEMBL3975668 0.83 CTSB (0.37) ADRB3ADRA2BADRA2CCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037214-A2 MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION INTERMUNE, INC. (US) 2005-04-28 — — WO disclosed
Send feedback